DJIA 17,052.23 -18.99 -0.11%
NASDAQ 4,494.13 -11.72 -0.26%
S&P 500 1,974.18 -3.62 -0.18%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

39.07 -1.11 (-2.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $39.17 -2.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.11
Previous Close $40.18
Daily Range $39.10 - $40.49
52-Week Range $22.25 - $62.66
Market Cap $4.6B
P/E Ratio -49.60
Dividend (Yield) $0.00 (0.0%)
Volume 169,162
Average Daily Volume 2,216,604
Current FY EPS -$0.70





Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

Bull vs. Bear: Isis Pharmaceuticals, Inc. Stock

Two analysts debate this rollercoaster biotech

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog

3 Biotechs Investors Should Watch

The healthcare version of Where the Money Is.

Jim Cramer's Top Stock Picks: ISIS DDD CY

Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Isis Pharmaceuticals (ISIS) Weak On High Volume Today

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH

See More ISIS News...

ISIS's Top Competitors

ISIS $39.07 (-2.76%)
Current stock: ISIS
AMGN $139.06 (-0.72%)
Current stock: AMGN
GILD $106.38 (-1.05%)
Current stock: GILD
BIIB $327.97 (-0.66%)
Current stock: BIIB